Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05653752
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2022-12-01
Brief Title:
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
Sponsor:
MediLink Therapeutics Suzhou Co Ltd
Organization:
MediLink Therapeutics Suzhou Co Ltd
Organization Data
Organization:
MediLink Therapeutics Suzhou Co Ltd
Class:
INDUSTRY
Study ID:
YL202-INT-101-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MediLink Therapeutics Suzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None